肿瘤患者PD-1治疗后出现大疱性类天疱疮1例
China Medical Abstracts of Dermatology（2021）
Abstract
抗肿瘤药物程序性死亡受体1(programmed death-1,PD-1)/程序性死亡配体1(programmed death ligand 1,PD-LI)免疫检查点抑制剂的应用常可引起免疫相关不良反应(immune-related adverse events,irAE).本文报道1例胆管细胞癌患者使用PD-1治疗后出现大疱性类天疱疮的病例,并做简要讨论.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined